PEGPH20 Shows Doubling of PFS in Pancreatic Cancer Patients with High Levels of Hyaluronan in Phase II Trial June 18, 2015Vol.38 No.06
Phase II Study Compares Afinitor as Second-Line Treatment Following Various VEGFR Inhibitors and Cytokine Therapy in Renal Cell Carcinoma June 18, 2015Vol.38 No.06
Retrospective Analysis Shows Benefit with Custirsen in mCRPC Patients with Poor Prognosis June 18, 2015Vol.38 No.06
Gilotrif Reduces Risk of Death by 19 Percent In Phase III Trial of Squamous Cell Carcinoma of the Lung June 18, 2015Vol.38 No.06
Tafinlar/Mekinist Combination Benefits BRAF V600E/K Mutation-Positive Melanoma Patients June 18, 2015Vol.38 No.06
Adding Imbruvica to Bendamustine/Rituximab Combination Increases PFS in Phase III Leukemia Trial June 18, 2015Vol.38 No.06
Drugs & Targets FDA Grants Orphan Designation for Reolysin in Malignant Glioma June 01, 2015Vol.38 No.05
APD403 Demonstrates Control of Nausea and Vomiting after Highly Emetogenic Chemotherapy June 01, 2015Vol.38 No.05
